Peyronie's Disease
- Predictors of Curvature Improvement in Men with Peyronie's Disease Treated with Intralesional Collagenase Clostridium Histolyticum. March 20, 2023Penile curvature is the most common abnormality that is observed by men with Peyronie's disease (PD). Collagenase Clostridium histolyticum (CCH) has become a standard treatment for PD patients.To identify predictor factors associated with improvements of penile curvature outcomes in men with PD treated with CCH.
- Incremental Treatment Response by Cycle With Collagenase Clostridium Histolyticum for Peyronie's Disease: a Pooled Analysis of Two Phase 3 Trials. March 6, 2023To evaluate cumulative and incremental changes in penile curvature after each treatment cycle of collagenase clostridium histolyticum (CCH) in men with Peyronie's disease (PD).Data from two phase 3, randomized, placebo-controlled trials were analyzed post hoc.
- Real-world practice in peyronie's disease management: Results from a national survey of urologists. February 27, 2023Despite many available treatments for Peyronie's disease (PD), practice patterns of available therapeutics are not well characterized.We conducted a national survey of urologists to characterize real-world practice patterns of PD management and to characterize the use of therapies discouraged by the American Urological Association guidelines on PD management.
What Is beyond 9%
Whether you’ve just been diagnosed with Peyronie’s disease or have known for some time, it can be difficult to see beyond the frustrations and limitations that regularly confront you. But rest assured, you’re not alone. In fact, more than 9% of men may develop Peyronie’s. At the APDA, we understand the challenges you’re facing. We’re patients, partners and physicians dealing with it each and every day. And we’re dedicated to helping you go beyond Peyronie’s and back to a more fulfilling life. Learn more
Welcome to APDA
Because the founder of the APDA has Peyronie’s disease, he understands what it’s like. Hear from him and members of the Medical Advisory Board about the organization and its mission to help patients become their own advocates.
If you could help other men with Peyronie’s disease get the help they deserve, would you?
Register for our newsletter!
To help you find answers and better understand this condition, a question-and-answer forum has been developed, where Dr. Laurence Levine and Dr. John Mulhall, along with other members of the APDA Medical Advisory Board and guest contributors, answer questions from patients and their partners. As leaders in Peyronie’s disease research and treatment, board members provide comprehensive and unbiased information about a broad range of topics.
